Loading…

Enhanced Oral Bioavailability of Piroxicam in Rats by Hyaluronate Microspheres

ABSTRACTTo enhance the dissolution and oral bioavailability of poorly water soluble piroxicam, the piroxicam-loaded hyaluronic microspheres were prepared with various ratios of piroxicam, sodium hyaluronate and polyethylene glycol 4000 (PEG) using a spray dryer, and their physicochemical properties...

Full description

Saved in:
Bibliographic Details
Published in:Drug development and industrial pharmacy 2007-04, Vol.33 (4), p.485-491
Main Authors: Piao, Ming Guan, Kim, Jeong-Hoon, Kim, Jong Oh, Lyoo, Won Seok, Lee, Mann Hyung, Yong, Chul Soon, Choi, Han-Gon
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3
cites cdi_FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3
container_end_page 491
container_issue 4
container_start_page 485
container_title Drug development and industrial pharmacy
container_volume 33
creator Piao, Ming Guan
Kim, Jeong-Hoon
Kim, Jong Oh
Lyoo, Won Seok
Lee, Mann Hyung
Yong, Chul Soon
Choi, Han-Gon
description ABSTRACTTo enhance the dissolution and oral bioavailability of poorly water soluble piroxicam, the piroxicam-loaded hyaluronic microspheres were prepared with various ratios of piroxicam, sodium hyaluronate and polyethylene glycol 4000 (PEG) using a spray dryer, and their physicochemical properties such as shape, size, drug-loading efficiency and dissolution were investigated. The pharmacokinetic study of piroxicam-loaded hyaluronic micropheres in rats was then performed compared to piroxicam powder. The piroxicam-loaded hyaluronic microspheres, spherical in shape, had the geometric mean diameters of about 1.5 μm and drug loading efficiency of about 90%, irrespective of ratio of piroxicam sodium hyaluronate PEG. The hyaluronic microspheres containing PEG gave significantly higher dissolution rates of drug than did piroxicam powder, PEG-based solid dispersion system and hyaluronic microspheres without PEG, suggesting that the hyaluronic microsphere with sodium hyaluronate and PEG was more useful for improving the dissolution rate of poorly water soluble piroxicam. The piroxicam-loaded hyaluronic microcapsule composed of (piroxicam sodium hyaluronate PEG; 2: 20: 1) gave about threefold improved dissolution of drug in water for 4 h compared to piroxicam powder. It showed higher plasma concentrations of drug compared to piroxicam powder. It gave significantly higher AUC and faster Tmax of piroxicam than did piroxicam powder. In particular, the AUC of piroxicam from hyaluronic microsphere was about twofold higher than that from piroxicam powder, suggesting that it could enhance the oral bioavailability of piroxicam. Thus, the hyaluronic microsphere developed using spray-drying technique with sodium hyaluronate and PEG was a more effective oral dosage form for poorly water soluble piroxicam.
doi_str_mv 10.1080/03639040600865223
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_03639040600865223</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70526133</sourcerecordid><originalsourceid>FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhi0EokvhAbggX-AWGNt1nAguUBWKVChCcI4mzljryokXOwHy9ni1iyqE1NNoNN8_mvkYeyrgpYAGXoGqVQtnUAM0tZZS3WMboSVU2tTyPtvs51UB9Al7lPMNgJCt1g_ZiTBaqtJt2OeLaYuTpYFfJwz8nY_4E33A3gc_rzw6_sWn-NtbHLmf-FecM-9XfrliWFKccCb-ydsU825LifJj9sBhyPTkWE_Z9_cX384vq6vrDx_P315VVgPM1dA2PSnr2t4Yqci1rnxgezGgNGZwQkgwsm2FNFLTmSXqUZMGdOgG0QtSp-zFYe8uxR8L5bkbfbYUAk4Ul9wZ0LIWShVQHMD9jTmR63bJj5jWTkC3l9j9J7Fknh2XL_1Iw23iaK0Az48AZovBpWLQ51uuaVRjDBTuzYHzk4tpxF8xhaGbcQ0x_Q2pu-54_U98SxjmrcVE3U1c0lQE3_HFHzsFnvc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70526133</pqid></control><display><type>article</type><title>Enhanced Oral Bioavailability of Piroxicam in Rats by Hyaluronate Microspheres</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><source>BSC - Ebsco (Business Source Ultimate)</source><creator>Piao, Ming Guan ; Kim, Jeong-Hoon ; Kim, Jong Oh ; Lyoo, Won Seok ; Lee, Mann Hyung ; Yong, Chul Soon ; Choi, Han-Gon</creator><creatorcontrib>Piao, Ming Guan ; Kim, Jeong-Hoon ; Kim, Jong Oh ; Lyoo, Won Seok ; Lee, Mann Hyung ; Yong, Chul Soon ; Choi, Han-Gon</creatorcontrib><description>ABSTRACTTo enhance the dissolution and oral bioavailability of poorly water soluble piroxicam, the piroxicam-loaded hyaluronic microspheres were prepared with various ratios of piroxicam, sodium hyaluronate and polyethylene glycol 4000 (PEG) using a spray dryer, and their physicochemical properties such as shape, size, drug-loading efficiency and dissolution were investigated. The pharmacokinetic study of piroxicam-loaded hyaluronic micropheres in rats was then performed compared to piroxicam powder. The piroxicam-loaded hyaluronic microspheres, spherical in shape, had the geometric mean diameters of about 1.5 μm and drug loading efficiency of about 90%, irrespective of ratio of piroxicam sodium hyaluronate PEG. The hyaluronic microspheres containing PEG gave significantly higher dissolution rates of drug than did piroxicam powder, PEG-based solid dispersion system and hyaluronic microspheres without PEG, suggesting that the hyaluronic microsphere with sodium hyaluronate and PEG was more useful for improving the dissolution rate of poorly water soluble piroxicam. The piroxicam-loaded hyaluronic microcapsule composed of (piroxicam sodium hyaluronate PEG; 2: 20: 1) gave about threefold improved dissolution of drug in water for 4 h compared to piroxicam powder. It showed higher plasma concentrations of drug compared to piroxicam powder. It gave significantly higher AUC and faster Tmax of piroxicam than did piroxicam powder. In particular, the AUC of piroxicam from hyaluronic microsphere was about twofold higher than that from piroxicam powder, suggesting that it could enhance the oral bioavailability of piroxicam. Thus, the hyaluronic microsphere developed using spray-drying technique with sodium hyaluronate and PEG was a more effective oral dosage form for poorly water soluble piroxicam.</description><identifier>ISSN: 0363-9045</identifier><identifier>EISSN: 1520-5762</identifier><identifier>DOI: 10.1080/03639040600865223</identifier><identifier>PMID: 17523012</identifier><language>eng</language><publisher>Colchester: Informa UK Ltd</publisher><subject>Administration, Oral ; Animals ; Anti-Inflammatory Agents, Non-Steroidal - chemistry ; Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics ; Area Under Curve ; Bbioavailability ; Biological and medical sciences ; Biological Availability ; Dissolution ; General pharmacology ; Hyaluronic Acid - chemistry ; In Vitro Techniques ; Male ; Medical sciences ; Microspheres ; Particle Size ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Piroxicam ; Piroxicam - chemistry ; Piroxicam - pharmacokinetics ; Polyethylene glycol ; Polyethylene Glycols - chemistry ; Powders ; Rats ; Rats, Wistar ; Sodium hyaluronate ; Solubility ; Technology, Pharmaceutical</subject><ispartof>Drug development and industrial pharmacy, 2007-04, Vol.33 (4), p.485-491</ispartof><rights>2007 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2007</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3</citedby><cites>FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18838770$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17523012$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Piao, Ming Guan</creatorcontrib><creatorcontrib>Kim, Jeong-Hoon</creatorcontrib><creatorcontrib>Kim, Jong Oh</creatorcontrib><creatorcontrib>Lyoo, Won Seok</creatorcontrib><creatorcontrib>Lee, Mann Hyung</creatorcontrib><creatorcontrib>Yong, Chul Soon</creatorcontrib><creatorcontrib>Choi, Han-Gon</creatorcontrib><title>Enhanced Oral Bioavailability of Piroxicam in Rats by Hyaluronate Microspheres</title><title>Drug development and industrial pharmacy</title><addtitle>Drug Dev Ind Pharm</addtitle><description>ABSTRACTTo enhance the dissolution and oral bioavailability of poorly water soluble piroxicam, the piroxicam-loaded hyaluronic microspheres were prepared with various ratios of piroxicam, sodium hyaluronate and polyethylene glycol 4000 (PEG) using a spray dryer, and their physicochemical properties such as shape, size, drug-loading efficiency and dissolution were investigated. The pharmacokinetic study of piroxicam-loaded hyaluronic micropheres in rats was then performed compared to piroxicam powder. The piroxicam-loaded hyaluronic microspheres, spherical in shape, had the geometric mean diameters of about 1.5 μm and drug loading efficiency of about 90%, irrespective of ratio of piroxicam sodium hyaluronate PEG. The hyaluronic microspheres containing PEG gave significantly higher dissolution rates of drug than did piroxicam powder, PEG-based solid dispersion system and hyaluronic microspheres without PEG, suggesting that the hyaluronic microsphere with sodium hyaluronate and PEG was more useful for improving the dissolution rate of poorly water soluble piroxicam. The piroxicam-loaded hyaluronic microcapsule composed of (piroxicam sodium hyaluronate PEG; 2: 20: 1) gave about threefold improved dissolution of drug in water for 4 h compared to piroxicam powder. It showed higher plasma concentrations of drug compared to piroxicam powder. It gave significantly higher AUC and faster Tmax of piroxicam than did piroxicam powder. In particular, the AUC of piroxicam from hyaluronic microsphere was about twofold higher than that from piroxicam powder, suggesting that it could enhance the oral bioavailability of piroxicam. Thus, the hyaluronic microsphere developed using spray-drying technique with sodium hyaluronate and PEG was a more effective oral dosage form for poorly water soluble piroxicam.</description><subject>Administration, Oral</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</subject><subject>Area Under Curve</subject><subject>Bbioavailability</subject><subject>Biological and medical sciences</subject><subject>Biological Availability</subject><subject>Dissolution</subject><subject>General pharmacology</subject><subject>Hyaluronic Acid - chemistry</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microspheres</subject><subject>Particle Size</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Piroxicam</subject><subject>Piroxicam - chemistry</subject><subject>Piroxicam - pharmacokinetics</subject><subject>Polyethylene glycol</subject><subject>Polyethylene Glycols - chemistry</subject><subject>Powders</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Sodium hyaluronate</subject><subject>Solubility</subject><subject>Technology, Pharmaceutical</subject><issn>0363-9045</issn><issn>1520-5762</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNp9kMFu1DAQhi0EokvhAbggX-AWGNt1nAguUBWKVChCcI4mzljryokXOwHy9ni1iyqE1NNoNN8_mvkYeyrgpYAGXoGqVQtnUAM0tZZS3WMboSVU2tTyPtvs51UB9Al7lPMNgJCt1g_ZiTBaqtJt2OeLaYuTpYFfJwz8nY_4E33A3gc_rzw6_sWn-NtbHLmf-FecM-9XfrliWFKccCb-ydsU825LifJj9sBhyPTkWE_Z9_cX384vq6vrDx_P315VVgPM1dA2PSnr2t4Yqci1rnxgezGgNGZwQkgwsm2FNFLTmSXqUZMGdOgG0QtSp-zFYe8uxR8L5bkbfbYUAk4Ul9wZ0LIWShVQHMD9jTmR63bJj5jWTkC3l9j9J7Fknh2XL_1Iw23iaK0Az48AZovBpWLQ51uuaVRjDBTuzYHzk4tpxF8xhaGbcQ0x_Q2pu-54_U98SxjmrcVE3U1c0lQE3_HFHzsFnvc</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Piao, Ming Guan</creator><creator>Kim, Jeong-Hoon</creator><creator>Kim, Jong Oh</creator><creator>Lyoo, Won Seok</creator><creator>Lee, Mann Hyung</creator><creator>Yong, Chul Soon</creator><creator>Choi, Han-Gon</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070401</creationdate><title>Enhanced Oral Bioavailability of Piroxicam in Rats by Hyaluronate Microspheres</title><author>Piao, Ming Guan ; Kim, Jeong-Hoon ; Kim, Jong Oh ; Lyoo, Won Seok ; Lee, Mann Hyung ; Yong, Chul Soon ; Choi, Han-Gon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - chemistry</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics</topic><topic>Area Under Curve</topic><topic>Bbioavailability</topic><topic>Biological and medical sciences</topic><topic>Biological Availability</topic><topic>Dissolution</topic><topic>General pharmacology</topic><topic>Hyaluronic Acid - chemistry</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microspheres</topic><topic>Particle Size</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Piroxicam</topic><topic>Piroxicam - chemistry</topic><topic>Piroxicam - pharmacokinetics</topic><topic>Polyethylene glycol</topic><topic>Polyethylene Glycols - chemistry</topic><topic>Powders</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Sodium hyaluronate</topic><topic>Solubility</topic><topic>Technology, Pharmaceutical</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Piao, Ming Guan</creatorcontrib><creatorcontrib>Kim, Jeong-Hoon</creatorcontrib><creatorcontrib>Kim, Jong Oh</creatorcontrib><creatorcontrib>Lyoo, Won Seok</creatorcontrib><creatorcontrib>Lee, Mann Hyung</creatorcontrib><creatorcontrib>Yong, Chul Soon</creatorcontrib><creatorcontrib>Choi, Han-Gon</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Drug development and industrial pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Piao, Ming Guan</au><au>Kim, Jeong-Hoon</au><au>Kim, Jong Oh</au><au>Lyoo, Won Seok</au><au>Lee, Mann Hyung</au><au>Yong, Chul Soon</au><au>Choi, Han-Gon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhanced Oral Bioavailability of Piroxicam in Rats by Hyaluronate Microspheres</atitle><jtitle>Drug development and industrial pharmacy</jtitle><addtitle>Drug Dev Ind Pharm</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>33</volume><issue>4</issue><spage>485</spage><epage>491</epage><pages>485-491</pages><issn>0363-9045</issn><eissn>1520-5762</eissn><abstract>ABSTRACTTo enhance the dissolution and oral bioavailability of poorly water soluble piroxicam, the piroxicam-loaded hyaluronic microspheres were prepared with various ratios of piroxicam, sodium hyaluronate and polyethylene glycol 4000 (PEG) using a spray dryer, and their physicochemical properties such as shape, size, drug-loading efficiency and dissolution were investigated. The pharmacokinetic study of piroxicam-loaded hyaluronic micropheres in rats was then performed compared to piroxicam powder. The piroxicam-loaded hyaluronic microspheres, spherical in shape, had the geometric mean diameters of about 1.5 μm and drug loading efficiency of about 90%, irrespective of ratio of piroxicam sodium hyaluronate PEG. The hyaluronic microspheres containing PEG gave significantly higher dissolution rates of drug than did piroxicam powder, PEG-based solid dispersion system and hyaluronic microspheres without PEG, suggesting that the hyaluronic microsphere with sodium hyaluronate and PEG was more useful for improving the dissolution rate of poorly water soluble piroxicam. The piroxicam-loaded hyaluronic microcapsule composed of (piroxicam sodium hyaluronate PEG; 2: 20: 1) gave about threefold improved dissolution of drug in water for 4 h compared to piroxicam powder. It showed higher plasma concentrations of drug compared to piroxicam powder. It gave significantly higher AUC and faster Tmax of piroxicam than did piroxicam powder. In particular, the AUC of piroxicam from hyaluronic microsphere was about twofold higher than that from piroxicam powder, suggesting that it could enhance the oral bioavailability of piroxicam. Thus, the hyaluronic microsphere developed using spray-drying technique with sodium hyaluronate and PEG was a more effective oral dosage form for poorly water soluble piroxicam.</abstract><cop>Colchester</cop><pub>Informa UK Ltd</pub><pmid>17523012</pmid><doi>10.1080/03639040600865223</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0363-9045
ispartof Drug development and industrial pharmacy, 2007-04, Vol.33 (4), p.485-491
issn 0363-9045
1520-5762
language eng
recordid cdi_crossref_primary_10_1080_03639040600865223
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list); BSC - Ebsco (Business Source Ultimate)
subjects Administration, Oral
Animals
Anti-Inflammatory Agents, Non-Steroidal - chemistry
Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics
Area Under Curve
Bbioavailability
Biological and medical sciences
Biological Availability
Dissolution
General pharmacology
Hyaluronic Acid - chemistry
In Vitro Techniques
Male
Medical sciences
Microspheres
Particle Size
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Piroxicam
Piroxicam - chemistry
Piroxicam - pharmacokinetics
Polyethylene glycol
Polyethylene Glycols - chemistry
Powders
Rats
Rats, Wistar
Sodium hyaluronate
Solubility
Technology, Pharmaceutical
title Enhanced Oral Bioavailability of Piroxicam in Rats by Hyaluronate Microspheres
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T12%3A05%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhanced%20Oral%20Bioavailability%20of%20Piroxicam%20in%20Rats%20by%20Hyaluronate%20Microspheres&rft.jtitle=Drug%20development%20and%20industrial%20pharmacy&rft.au=Piao,%20Ming%20Guan&rft.date=2007-04-01&rft.volume=33&rft.issue=4&rft.spage=485&rft.epage=491&rft.pages=485-491&rft.issn=0363-9045&rft.eissn=1520-5762&rft_id=info:doi/10.1080/03639040600865223&rft_dat=%3Cproquest_cross%3E70526133%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c500t-d98be3cf9b7723ef9f008cb1da277df1120729912725e4ceeba5e50afafd1b1e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70526133&rft_id=info:pmid/17523012&rfr_iscdi=true